| [1] |
Marks R. An overview of skin cancers. Incidence and causation[J]. Cancer, 1995, 75(2 Suppl): 607-12.
|
| [2] |
Silva MT, Galvao TF, Zimmerman IR,et al. Non-aspirin non-steroidal anti-inflammatory drugs for the primary chemoprevention of non-gastrointestinal cancer: summary of evidence[J].Curr Pharm Des, 2012, 18(26): 4047-70.
|
| [3] |
Grau de Castro JJ.COX-2 inhibitors in cancer prevention[J].Rev Clin Esp, 2005, 205(9): 446-56.
|
| [4] |
Asgari MM, Maruti SS, White E. A large cohort study of nonsteroidal anti-inflammatory drug use and melanoma incidence[J].J Natl Cancer Inst, 2008, 100(13): 967-71.
|
| [5] |
Joosse A, Koomen ER, Casparie MK, et al. Non-steroidal antiinflammatory drugs and melanoma risk: large Dutch populationbased case-control study[J].J Invest Dermatol, 2009, 129(11): 26 20-7.
|
| [6] |
Clouser MC, Roe DJ, Foote JA, et al. Effect of non-steroidal antiinflammatory drugs on non-melanoma skin cancer incidence in the SKICAP-AK trial[J].Pharmacoepidemiol Drug Saf, 2009,18(4): 276-83.
|
| [7] |
Asgari MM, Chren MM, Warton EM, et al. Association between nonsteroidal anti-inflammatory drug use and cutaneous squamous cell carcinoma[J].Arch Dermatol, 2010, 146(4): 388-95.
|
| [8] |
Curiel-Lewandrowski C, Nijsten T, Gomez ML, et al. Long-term use of nonsteroidal anti-inflammatory drugs decreases the risk of cutaneous melanoma: results of a United States case-control study[J].J Invest Dermatol, 2011, 131(7): 1460-8.
|
| [9] |
Jeter JM, Bonner JD, Johnson TM, et al. Nonsteroidal antiinflammatory drugs and risk of melanoma[J].J Skin Cancer, 2011, 20 11: 598571.
|
| [10] |
Jeter JM, Han J, Martinez ME, et al. Non-steroidal antiinflammatory drugs, acetaminophen, and risk of skin cancer in the Nurses' Health Study[J].Cancer Causes Control, 2012, 23(9): 14 51-61.
|
| [11] |
Johannesdottir SA, Chang ET, Mehnert F, et al. Nonsteroidal antiinflammatory drugs and the risk of skin cancer: a populationbased case-control study[J].Cancer, 2012, 118(19): 4768-76.
|
| [12] |
Cahoon EK, Rajaraman P, Alexander BH, et al. Use of nonsteroidal anti-inflammatory drugs and risk of basal cell carcinoma in the United States Radiologic Technologists study[J]. Int J Cancer, 2012, 130(12): 2939-48.
|
| [13] |
Gamba CA,Swetter SM,Stefanick ML,et al. Aspirin is associated with lower melanoma risk among postmenopausal Caucasian women: The Women's Health Initiative[J].Cancer, 2013, 11 9(8):1562-9.
|
| [14] |
Jadad AR, Moore RA, Carroll D, et al. Assessing the quality of reports of randomized clinical trials: is blinding necessary?[J]. Control Clin Trials, 1996, 17(1): 1-12.
|
| [15] |
Cota GF, de Sousa MR, Fereguetti TO, et al. Efficacy of antileishmania therapy in visceral leishmaniasis among HIV infected patients: a systematic review with indirect comparison[J].PLoS Negl Trop Dis, 2013, 7(5): e2195.
|
| [16] |
Begg CB, Mazumdar M. Operating characteristics of a rank correlation test for publication bias[J].Biometrics, 1994, 50(4): 10 88-101.
|
| [17] |
Egger M, Davey SG, Schneider M, et al. Bias in meta-analysis detected by a simple, graphical test[J].BMJ, 1997, 315(7109): 62 9-34.
|
| [18] |
Masferrer JL, Leahy KM, Koki AT, et al. Antiangiogenic and antitumor activities of cyclooxygenase-2 inhibitors[J].Cancer Res, 20 00, 60(5): 1306-11.
|
| [19] |
Denkert C, Köbel M, Berger S, et al. Expression of cyclooxygenase 2 in human malignant melanoma[J].Cancer Res, 20 01, 61(1): 303-8.
|
| [20] |
An KP, Athar M, Tang X, et al.Cyclooxygenase-2 expression in murine and human nonmelanoma skin cancers: implications for therapeutic approaches[J].Photochem Photobiol, 2002, 76(1): 73 -80.
|
| [21] |
Fischer SM. Is cyclooxygenase-2 important in skin carcinogenesis[J]. J Environ Pathol Toxicol Oncol, 2002, 21(2): 183-91.
|
| [22] |
Fürstenberger G, Marks F, Müller-Decker K.Cyclooxygenase-2 and skin carcinogenesis[J].Prog Exp Tumor Res, 2003, 37: 72-89.
|
| [23] |
Vogel U, Christensen J, Wallin H, et al. Polymorphisms in COX-2, NSAID use and risk of basal cell carcinoma in a prospective study of Danes[J].Mutat Res, 2007, 617(1-2): 138-46.
|
| [24] |
Elmets CA, Viner JL, Pentland AP, et al. Chemoprevention of nonmelanoma skin cancer with celecoxib: a randomized, doubleblind, placebo-controlled trial[J].J Natl Cancer Inst, 2010, 10 2(24): 1835-44.
|
| [25] |
Hassan E. Recall bias can be a threat to retrospective and prospective research designs[J]. Int J Epidemiol, 2005, 3(2): 4-4.
|
| [26] |
Asgari M, White E, Chren MM. Nonsteroidal anti-inflammatory drug use in the prevention and treatment of squamous cell carcinoma[J].Dermatol Surg, 2004, 30(10): 1335-42.
|
下载:
